Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 455

1.

Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms.

Fornai M, Colucci R, Antonioli L, Awwad O, Ugolini C, Tuccori M, Fulceri F, Natale G, Basolo F, Blandizzi C.

Pharmacol Res. 2011 Jan;63(1):59-67. doi: 10.1016/j.phrs.2010.10.013. Epub 2010 Oct 20.

PMID:
20969958
2.

Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment.

Colucci R, Fornai M, Antonioli L, Ghisu N, Tuccori M, Blandizzi C, Del Tacca M.

Dig Liver Dis. 2009 Jun;41(6):395-405. doi: 10.1016/j.dld.2008.10.004. Epub 2009 Feb 28.

PMID:
19251492
3.

Effects of pantoprazole on ulcer healing delay associated with NSAID treatment.

Fornai M, Colucci R, Antonioli L, Ghisu N, Tuccori M, Blandizzi C, Del Tacca M.

Naunyn Schmiedebergs Arch Pharmacol. 2009 Mar;379(3):305-13. doi: 10.1007/s00210-008-0355-y. Epub 2008 Oct 14.

PMID:
18853145
4.

Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing.

Colucci R, Antonioli L, Bernardini N, Ippolito C, Segnani C, Awwad O, Tuccori M, Blandizzi C, Scarpignato C, Fornai M.

J Pharmacol Exp Ther. 2012 Jul;342(1):140-9. doi: 10.1124/jpet.111.190116. Epub 2012 Apr 10.

5.

Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.

Fornai M, Natale G, Colucci R, Tuccori M, Carazzina G, Antonioli L, Baldi S, Lubrano V, Abramo A, Blandizzi C, Del Tacca M.

Naunyn Schmiedebergs Arch Pharmacol. 2005 Jul;372(1):79-87. Epub 2005 Aug 4.

PMID:
16080005
6.

Lansoprazole protects and heals gastric mucosa from non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fas-mediated death pathways with concurrent induction of mucosal cell renewal.

Maity P, Bindu S, Choubey V, Alam A, Mitra K, Goyal M, Dey S, Guha M, Pal C, Bandyopadhyay U.

J Biol Chem. 2008 May 23;283(21):14391-401. doi: 10.1074/jbc.M800414200. Epub 2008 Mar 28.

7.

Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage.

Blandizzi C, Fornai M, Colucci R, Natale G, Lubrano V, Vassalle C, Antonioli L, Lazzeri G, Del Tacca M.

World J Gastroenterol. 2005 Jul 14;11(26):4052-60.

8.

Gastric acid is the key modulator in the pathogenesis of non-steroidal anti-inflammatory drug-induced ulceration in rats.

Zinkievich JM, George S, Jha S, Nandi J, Levine RA.

Clin Exp Pharmacol Physiol. 2010 Jul;37(7):654-61. doi: 10.1111/j.1440-1681.2010.05357.x. Epub 2010 Jan 17.

PMID:
20082628
9.

Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.

Brzozowski T, Konturek PC, Konturek SJ, Sliwowski Z, Pajdo R, Drozdowicz D, Ptak A, Hahn EG.

Microsc Res Tech. 2001 Jun 1;53(5):343-53.

PMID:
11376495
10.

Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds.

Natale G, Lazzeri G, Lubrano V, Colucci R, Vassalle C, Fornai M, Blandizzi C, Del Tacca M.

Toxicol Appl Pharmacol. 2004 Feb 15;195(1):62-72.

PMID:
14962506
11.

Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility.

Satoh H, Amagase K, Takeuchi K.

J Pharmacol Exp Ther. 2012 Nov;343(2):270-7. doi: 10.1124/jpet.112.197475. Epub 2012 Aug 1.

12.

Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.

Takeuchi K, Suzuki K, Yamamoto H, Araki H, Mizoguchi H, Ukawa H.

J Physiol Pharmacol. 1998 Dec;49(4):501-13.

PMID:
10069692
13.

Ellagic acid facilitates indomethacin-induced gastric ulcer healing via COX-2 up-regulation.

Chatterjee A, Chatterjee S, Das S, Saha A, Chattopadhyay S, Bandyopadhyay SK.

Acta Biochim Biophys Sin (Shanghai). 2012 Jul;44(7):565-76. doi: 10.1093/abbs/gms034. Epub 2012 May 24.

PMID:
22626975
14.

Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers.

Nishino M, Sugimoto M, Kodaira C, Yamade M, Uotani T, Shirai N, Ikuma M, Tanaka T, Sugimura H, Hishida A, Furuta T.

J Clin Pharmacol. 2011 Jul;51(7):1079-86. doi: 10.1177/0091270010376194. Epub 2010 Jul 27.

PMID:
20663999
15.

Effects of lansoprazole on the expression of VEGF and cellular proliferation in a rat model of acetic acid-induced gastric ulcer.

Kobayashi S, Nakajima N, Ito Y, Moriyama M.

J Gastroenterol. 2010 Aug;45(8):846-58. doi: 10.1007/s00535-010-0224-6. Epub 2010 Mar 24.

PMID:
20333532
16.

Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effects.

Suzuki T, Yamaguchi T, Odaka T, Kobayashi M, Seza A, Kouzu T, Yokosuka O.

Aliment Pharmacol Ther. 2008 Jan 1;27(1):66-71. Epub 2007 Oct 8.

17.

Gastroprotective and antioxidant effects of montelukast on indomethacin-induced gastric ulcer in rats.

Dengiz GO, Odabasoglu F, Halici Z, Cadirci E, Suleyman H.

J Pharmacol Sci. 2007 Sep;105(1):94-102.

19.

Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.

Brzozowski T, Konturek PC, Konturek SJ, Sliwowski Z, Drozdowicz D, KwiecieĊ„ S, Pajdo R, Ptak A, Pawlik M, Hahn E.

Dig Liver Dis. 2000 Oct;32(7):583-94.

PMID:
11142556
20.

Protective activity of crocin against indomethacin-induced gastric lesions in rats.

Mard SA, Pipelzadeh MH, Teimoori A, Neisi N, Mojahedin S, Khani MZ, Ahmadi I.

J Nat Med. 2016 Jan;70(1):62-74. doi: 10.1007/s11418-015-0938-0. Epub 2015 Oct 6.

PMID:
26439477

Supplemental Content

Support Center